94 related articles for article (PubMed ID: 24054991)
1. Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study.
van Exel E; Eikelenboom P; Comijs H; Deeg DJ; Stek ML; Westendorp RG
Neurobiol Aging; 2014 Mar; 35(3):725.e7-10. PubMed ID: 24054991
[TBL] [Abstract][Full Text] [Related]
2. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
van Exel E; Eikelenboom P; Comijs H; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
Arch Gen Psychiatry; 2009 Nov; 66(11):1263-70. PubMed ID: 19884614
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
[TBL] [Abstract][Full Text] [Related]
4. Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.
van Vliet P; Westendorp RG; Eikelenboom P; Comijs HC; Frölich M; Bakker E; van der Flier W; van Exel E
Neurology; 2009 Sep; 73(9):681-7. PubMed ID: 19720974
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
6. IGF-I gene variability is associated with an increased risk for AD.
Vargas T; Martinez-Garcia A; Antequera D; Vilella E; Clarimon J; Mateo I; Sanchez-Juan P; Rodriguez-Rodriguez E; Frank A; Rosich-Estrago M; Lleo A; Molina-Porcel L; Blesa R; Gomez-Isla T; Combarros O; Bermejo-Pareja F; Valdivieso F; Bullido MJ; Carro E
Neurobiol Aging; 2011 Mar; 32(3):556.e3-11. PubMed ID: 21176999
[TBL] [Abstract][Full Text] [Related]
7. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
9. [The immune system and Alzheimer's disease].
van Exel E; Eikelenboom P; Comijs HC; Kurniawan C; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
Tijdschr Psychiatr; 2011; 53(9):637-43. PubMed ID: 21898320
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
14. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
16. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
17. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.
Holmes C; Russ C; Kirov G; Aitchison KJ; Powell JF; Collier DA; Lovestone S
Biol Psychiatry; 1998 Feb; 43(3):159-64. PubMed ID: 9494696
[TBL] [Abstract][Full Text] [Related]
19. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]